Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication

Reto D Kurmann1, Edward A El-Am2, Yasser A Radwan3

  • 1R.D. Kurmann, MD, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA, and Department of Cardiology, Heart Center Lucerne Hospital, Lucerne, Switzerland.

Insights

Systemic sclerosis (SSc) patients show a fourfold higher prevalence and incidence of moderate/severe valvular heart disease (VHD) compared to non-SSc individuals. This highlights a significant association between SSc and VHD development.

Area of Science:

  • Cardiology
  • Rheumatology
  • Systemic Autoimmune Diseases

Background:

  • Cardiac involvement is a critical prognostic factor in systemic sclerosis (SSc).
  • While myocardial fibrosis and arrhythmias are recognized, valvular heart disease (VHD) incidence in SSc is underreported.
  • Understanding VHD prevalence is crucial for comprehensive SSc patient care.

Purpose of the Study:

  • To determine the prevalence of VHD at SSc diagnosis.
  • To assess the incidence of VHD during follow-up in SSc patients compared to non-SSc subjects.
  • To investigate the association between SSc and VHD development.

Main Methods:

  • Retrospective review of medical records for incident SSc cases.
  • Matching of SSc subjects 1:2 by age and sex to non-SSc control subjects.
  • Comparison of VHD prevalence at diagnosis and incidence over time.

Main Results:

  • A nearly fourfold increase in moderate/severe VHD prevalence was observed in SSc patients at diagnosis (6% vs 0%).
  • The cumulative incidence of VHD at 10 years was significantly higher in SSc patients (17.9%) versus non-SSc subjects (2.3%).
  • Aortic stenosis and mitral regurgitation were more prevalent in SSc, alongside secondary tricuspid regurgitation.

Conclusions:

  • SSc patients exhibit a fourfold higher prevalence of moderate/severe VHD at diagnosis.
  • SSc patients face a fourfold increased risk of developing moderate/severe VHD post-diagnosis.
  • Further research is needed to elucidate the underlying mechanisms connecting SSc and VHD.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
191
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
227
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
128
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
153
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
126